| The effect of pregabalin on preoperative anxiety and sedation levels: a dose-ranging study. | |
| | |
MedLine Citation:
|
PMID: 19299776 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Pregabalin is a gabapentinoid compound, which has been alleged to possess anxiolytic, analgesic, and anticonvulsant properties. We hypothesized that premedication with oral pregabalin would produce dose-related reductions in acute (state) anxiety and increases in sedation (sleepiness) before induction of general anesthesia. A secondary objective was to determine if premedication with pregabalin would reduce postoperative pain. METHODS: One hundred eight ASA I-III outpatients undergoing elective surgery were randomly assigned to one of the four premedication treatment groups: 1) control group received placebo capsules, 2) pregabalin 75 group received pregabalin 75 mg, po, 3) pregabalin 150 group received pregabalin 150 mg, po, and 4) pregabalin 300 group received pregabalin 300 mg, po. The effects of the study drug on the patients' level of anxiety, sedation, and pain were assessed at baseline (immediately before study drug administration), at 30 and 60 min after drug administration, and immediately before induction of anesthesia, as well as at 30-min intervals in the postanesthesia care unit (PACU) using standardized 11-point verbal rating scales, with 0 = none to 10 = maximal effect. The need for postoperative opioid analgesic medication, incidence of nausea and vomiting, requirement for rescue antiemetics, and times to discharge from the PACU and hospital, as well as the patients' quality of recovery scores, and late recovery outcomes (e.g., resumption of dietary intake and recovery of bowel function) were assessed at a 7-day follow-up interview. RESULTS: Demographic characteristics, times between study drug administration to anesthetic induction, type of surgical procedures, duration of anesthesia, PACU and hospital discharge time, as well as the requirement for fentanyl in the PACU, did not differ among the four study groups. Anxiety levels remained unchanged during the preoperative evaluation period, and did not differ among the four study groups. Sedation scores were significantly higher in the pregabalin 300 group at the preinduction assessment interval and at 90 and 120 min after surgery compared with the control group (5 +/- 3 vs 3 +/- 2, 7 +/- 4 vs 5 +/- 3, 8 +/- 4 vs 4 +/- 4, respectively, P < 0.05). CONCLUSION: Preoperative pregabalin administration (75-300 mg po) increased perioperative sedation in a dose-related fashion, but failed to reduce preoperative state anxiety, postoperative pain, or to improve the recovery process after minor elective surgery procedures. |
| | |
Authors:
|
Paul F White; Burcu Tufanogullari; Jimmie Taylor; Kevin Klein |
Related Documents
:
|
1224936 - Myocardial contractility during peridural anesthesia. 18382796 - Remifentanil versus fentanyl in combination with midazolam for retrobulbar block in cat... 2719296 - Timing of the anesthetist's preoperative outpatient interview. 20863926 - A comparative study among three techniques of general anesthesia for ultrasound-guided ... 12595766 - Comprehensive deep venous thrombosis prevention strategy after total-knee arthroplasty. 19796586 - Ankle function and sports activity after total ankle arthroplasty. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Anesthesia and analgesia Volume: 108 ISSN: 1526-7598 ISO Abbreviation: Anesth. Analg. Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-03-20 Completed Date: 2009-04-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1310650 Medline TA: Anesth Analg Country: United States |
Other Details:
|
Languages: eng Pagination: 1140-5 Citation Subset: AIM; IM |
Affiliation:
|
Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9068, USA. paul.white@utsouthwestern.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Adult Analgesics / administration & dosage*, adverse effects Analgesics, Opioid / therapeutic use Anti-Anxiety Agents / administration & dosage*, adverse effects Antiemetics / therapeutic use Anxiety / etiology, prevention & control* Capsules Dose-Response Relationship, Drug Double-Blind Method Female Fentanyl / therapeutic use Humans Hypnotics and Sedatives / administration & dosage*, adverse effects Length of Stay Male Middle Aged Pain Measurement Pain, Postoperative / prevention & control* Postoperative Nausea and Vomiting / etiology, prevention & control Preanesthetic Medication* Recovery of Function Sleep / drug effects* Surgical Procedures, Elective / psychology Time Factors gamma-Aminobutyric Acid / administration & dosage, adverse effects, analogs & derivatives* |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics; 0/Analgesics, Opioid; 0/Anti-Anxiety Agents; 0/Antiemetics; 0/Capsules; 0/Hypnotics and Sedatives; 0/pregabalin; 437-38-7/Fentanyl; 56-12-2/gamma-Aminobutyric Acid |
| Comments/Corrections | |
Comment In:
|
Anesth Analg. 2009 Apr;108(4):1058-61
[PMID:
19299761
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Subtenon block compared to intravenous fentanyl for perioperative analgesia in pediatric cataract su...
Next Document: Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes bett...